Roche Diagnostics Inks Second ProBNP Test Development Deal
This article was originally published in The Gray Sheet
Executive Summary
Syn X Pharma aims to bring its NT-proBNP Nexus Dx point-of-care test for the detection of congestive heart failure to the U.S. market by the second half of 2004